IN VIVO EXPRESSION OF THE INTERLEUKIN 4 RECEPTOR ALPHA BY ASTROCYTES IN EPILEPSY CEREBRAL CORTEX

Cytokine ◽  
2000 ◽  
Vol 12 (11) ◽  
pp. 1656-1661 ◽  
Author(s):  
Haiyan Liu ◽  
Richard A Prayson ◽  
Melinda L Estes ◽  
Judith A Drazba ◽  
Gene H Barnett ◽  
...  
2018 ◽  
Vol 9 ◽  
Author(s):  
Hlumani Ndlovu ◽  
Justin Komguep Nono ◽  
Nada Abdel Aziz ◽  
Natalie Eva Nieuwenhuizen ◽  
Frank Brombacher

2016 ◽  
Vol 46 (10) ◽  
pp. 2311-2321 ◽  
Author(s):  
Lucy H. Jackson-Jones ◽  
Dominik Rückerl ◽  
Freya Svedberg ◽  
Sheelagh Duncan ◽  
Rick M. Maizels ◽  
...  

1997 ◽  
Vol 6 (2) ◽  
pp. 111-118 ◽  
Author(s):  
B. Niggemann ◽  
T. Zuberbier ◽  
U. Herz ◽  
K. Enssle ◽  
U. Wahn ◽  
...  

The aim of the study was to analyse the effect of interleukin-4 (IL-4) on allergen and anti-IgE mediated histamine release from basophils and human skin mast cells and to assess whether soluble recombinant interleukin-4 receptor (sIL4R) can inhibit these effects. Anti-IgE stimulated histamine release from peripheral blood basophils and mast cells of atopic donors was enhanced after preincubation with IL-4, whereas after preincubation with sIL-4R it was inhibited. These effects were even more pronounced when samples were stimulated with a clinically relevant allergen. In IL-4 preincubated skin mast cells, there was a similar enhancement of anti-IgE stimulated histamine release, which could again be inhibited by sIL-4R. The effects of IL-4 and sIL4R were dose- and time-dependent. Mice sensitized to ovalbumin and treated with soluble recombinant murine sIL-4R showed significantly reduced immediate-type cutaneous hypersensitivity responses compared with untreated mice. Thesein vivoeffects were IgE independent, since there were no significant differences in total and allergen specific IgE/IgG1 antibody titres between treated and untreated mice. This indicates that IL4 exerts priming effects on histamine release by effector cells of the allergic response and that these effects are potently antagonized by soluble IL-4R bothin vitroandin vivo.


2007 ◽  
Vol 14 (4) ◽  
pp. 369-374 ◽  
Author(s):  
Stephanie Jacks ◽  
Steeve Giguère ◽  
John F. Prescott

ABSTRACT Rhodococcus equi is a facultative intracellular pathogen that causes pneumonia in foals but does not induce disease in adult horses. Virulence of R. equi depends on the presence of a large plasmid, which encodes a family of seven virulence-associated proteins (VapA and VapC to VapH). Eradication of R. equi from the lungs depends on gamma interferon (IFN-γ) production by T lymphocytes. The objectives of the present study were to determine the relative in vivo expression of the vap genes of R. equi in the lungs of infected foals, to determine the recall response of bronchial lymph node (BLN) lymphocytes from foals and adult horses to each of the Vap proteins, and to compare the cytokine profiles of proliferating lymphocytes between foals and adult horses. vapA, vapD, and vapG were preferentially expressed in the lungs of infected foals, and expression of these genes in the lungs was significantly (P < 0.05) higher than that achieved during in vitro growth. VapA and VapC induced the strongest lymphoproliferative responses for foals and adult horses. There was no significant difference in recall lymphoproliferative responses or IFN-γ mRNA expression by bronchial lymph node lymphocytes between foals and adults. In contrast, interleukin 4 (IL-4) expression was significantly higher for adults than for foals for each of the Vap proteins. The ratio of IFN-γ to IL-4 was significantly higher for foals than for adult horses for most Vap proteins. Therefore, foals are immunocompetent and are capable of mounting lymphoproliferative responses of the same magnitude and cytokine phenotype as those of adult horses.


2018 ◽  
Vol 47 (7) ◽  
pp. 680-688
Author(s):  
Shamsolmoulouk Najafi ◽  
Mahsa Mohammadzadeh ◽  
Fateme Rajabi ◽  
Alireza Zare Bidoki ◽  
Hila Yousefi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document